Safety and Survival Associated with Biologic Therapies: First Report of the Biobadaguay on the Paraguayan-Uruguayan Registry of Adverse Events with Biologic Therapies. [electronic resource]
Producer: 20210902Description: 396-404 p. digitalISSN:- 2173-5743
- Adalimumab -- adverse effects
- Adult
- Antibodies, Monoclonal, Humanized -- adverse effects
- Antirheumatic Agents -- adverse effects
- Arthritis, Juvenile -- drug therapy
- Arthritis, Rheumatoid -- drug therapy
- Biological Products -- adverse effects
- Female
- Humans
- Male
- Middle Aged
- Paraguay
- Prospective Studies
- Registries
- Survival Rate
- Uruguay
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.